Emagix

Halifax, Canada

Emagix is focused on improving diagnosis and assessment measures by analyzing blood flow dynamics. Our proprietary software algorithm provides an objective assessment of which blood vessels are compromised, and to what extent. This vital tool gives clinicians the information they need to diagnose disease earlier, and to provide treatment that is better focused, in order to stop disease progression in its tracks.What if you could easily quantify leakage, flow and volume in retinal blood vessels?Our patented RetiCAD (Retinal Computer-Aided Diagnosis) software extracts unique data and new insights from retinal image sets acquired from routine fluorescein angiography procedures performed using conventional fundus cameras, and uses them to provide a highly accurate, sensitive and quantitative view of vascular health and integrity in the retina.Our technology transforms a highly subjective procedure into one that gives quantitative results, important new insights, and is up to 75% faster; all without requiring an investment in new equipment.

✓Source: HealthTech Alpha by Galen Growth

Shareable draft

Check out Emagix on @MedStartr Today #CardiovascularHealth #VascularDiseases #RetinalDisease #EyeDisorders #Diagnostics #MedMo #MedStartrVentures

https://www.medstartr.ai/s/2goyBb7i9PM

Get Involved in Emagix

🏢Is this your company? Claim This Profile

Join MedStartr to verify with your work email and edit this profile

Company Info

Founded: 2016
Website: www.emagix.ca/

Disease Areas

Cardiovascular Health Vascular Diseases Retinal Disease Eye Disorders

Technologies

Diagnostic ImagingMedical Image AnalysisImage Processing & ReconstructionMRI

🌐Website

MedStartr Engagement Score

The MedStartr Index is a reflection of how the crowds that come to MedStartr everyday to find healthcare innovations reacted. Calculated by our AI agent Fyggy based on algorithms we have been building since 2012 and over 100 different factors, the math is proprietary and complex. Suffice to say, it has been found to be highly correlative with early stage company growth. What you see here is the public version. To learn more or to get deeper access to our predictive data on startup success for your fund or company, click here.

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Be the first to comment.

What do you think of Emagix?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.